Efficacy and Safety Evaluation for the Treatment of Allergy Against Mites

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2020
A double-blinded, placebo-controlled, prospective, multicenter randomized of 2 active treatment groups, compared to 1 placebo group, for the determination of the efficacy and safety of subcutaneous immunotherapy in patients with rhinitis/rhinoconjunctivitis with mild to moderate asthma, sensitised to Dermatophagoides pteronyssinus and /or Dermatophagoides farinae.
Epistemonikos ID: 60bb4fe9933cade1517dc967ab739b3b115cbc7c
First added on: May 07, 2024